Inllmed.aibyRanjani RamamurthyPediatric AML: Starting with the scienceThanks to Dr. Soheil Meshinchi MD, PhD and Julie A. Guillot for their input and for sharing content for this article. Much gratitude for…Sep 6, 2022
Drew DotsonGrief Gab: How I got hereI became a widow July 20, 2020. Here’s the short version of how it happened.May 26, 20221
The Leukemia & Lymphoma SocietyFDA Approval of New Treatment Option for Children with Secondary Acute Myeloid Leukemia is a…By Gwen Nichols, MD, LLS Chief Medical Officer | March, 2021Apr 4, 2021Apr 4, 2021
InHKU MedicinebyHKUMedPersonalising Treatment for One of the Most Lethal Cancers“For the 60–70% patients who do not respond well to conventional chemotherapy, we hope by understanding their unique genetic underpinnings…Sep 28, 2020Sep 28, 2020
The Leukemia & Lymphoma SocietyBeat AML in the Time of COVID-19: A Powerful New VideoLike many clinical trials across the U.S. and the globe, The Leukemia & Lymphoma’s Beat AML Master Trial has been dramatically impacted by…May 15, 2020May 15, 2020
Inllmed.aibyRanjani RamamurthyPediatric AML: Starting with the scienceThanks to Dr. Soheil Meshinchi MD, PhD and Julie A. Guillot for their input and for sharing content for this article. Much gratitude for…Sep 6, 2022
Drew DotsonGrief Gab: How I got hereI became a widow July 20, 2020. Here’s the short version of how it happened.May 26, 20221
The Leukemia & Lymphoma SocietyFDA Approval of New Treatment Option for Children with Secondary Acute Myeloid Leukemia is a…By Gwen Nichols, MD, LLS Chief Medical Officer | March, 2021Apr 4, 2021
InHKU MedicinebyHKUMedPersonalising Treatment for One of the Most Lethal Cancers“For the 60–70% patients who do not respond well to conventional chemotherapy, we hope by understanding their unique genetic underpinnings…Sep 28, 2020
The Leukemia & Lymphoma SocietyBeat AML in the Time of COVID-19: A Powerful New VideoLike many clinical trials across the U.S. and the globe, The Leukemia & Lymphoma’s Beat AML Master Trial has been dramatically impacted by…May 15, 2020
Mission BioMD Anderson Analyzes AML With Tapestri, Unveiling New Therapy Response PatternsBy Charlie Silver, Co-Founder & CEO, Mission BioApr 20, 2020
Michael VinyardMy first paper has been published!CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AMLJan 20, 2020
Mission BioHow Mission Bio is Helping Outsmart Cancer, As Demonstrated by UCSF & PennBy Charlie Silver, Co-Founder & CEO, Mission BioMay 22, 20192
